OTHER INFORMATION.
−Removed: On November 1, 2023, the board of directors approved an amendment to the
−Removed: employment agreement of the Company’s Chief Executive Officer and Chairman of the board of directors, Sandesh Seth, pursuant to
−Removed: which the term of Mr.
−Removed: Seth’s employment was extended from February 21, 2024 to February 21, 2027, subject to the terms of the employment
Copies of the following documents
12 unchanged sentences
Amendment to Amended and Restated Bylaws, dated May 7, 2020 (incorporated by reference to Exhibit 3.1 to Form 8-K filed on May 5, 2020).
−Removed: Amendment to Employment Agreement, dated November 1, 2023, by and between Actinium Pharmaceuticals, Inc.
−Removed: and Sandesh Seth .
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
10 unchanged sentences
Inline XBRL Taxonomy Presentation Linkbase Document
−Removed: Cover Page Interactive Data File (formatted as Inline
−Removed: XBRL and contained in Exhibit 101).
−Removed: a management contract or compensatory plan or arrangement.
+Added: Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
+Added: Filed herewith.
+Added: Furnished herewith.
Pursuant to the requirements
2 unchanged sentences
ACTINIUM PHARMACEUTICALS, INC.
−Removed: November 2, 2023
+Added: April 26, 2024
/s/ Sandesh Seth
8 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.